Respiratory muscle training moderately improved lung function, especially respiratory muscle strength, in patients with amyotrophic lateral sclerosis (ALS) compared with no intervention or sham ...

The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process ...

Living close to water bodies with blue-green algae blooms, or cyanobacteria, is linked to significantly reduced survival among people with amyotrophic lateral sclerosis (ALS), according to a new study ...

Recent brain-computer-interface (BCI) devices have made it possible to translate neural activity directly into text and even ...

Living close to cyanobacterial harmful algal blooms in US water bodies is associated with increased risk of mortality from ALS.

In May 2024, physicians notified Keil that he had amyotrophic lateral sclerosis (ALS). ALS is a neurological illness that makes it difficult for a person to use their muscles over time. His friends ...

The global amyotrophic lateral sclerosis treatment market is undergoing gradual yet impactful transformation, driven by ...

Exposure to toxic cyanobacterial blooms may accelerate fatal outcomes in amyotrophic lateral sclerosis linked to ...

including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today provided a regulatory update following a Type C meeting with the U.S. Food and Drug Administration (FDA), and announced ...